Cytomegalovirus ileitis and hemophagocytic syndrome associated with use of anti-tumor necrosis factor-α antibody [9]

Clinical Infectious Diseases

Volumn 42, Issue 5, 2006, Pages 733-734

  Kohara, Michelle M ^a   Blum, Ray N ^b  

^a Exempla Saint Joseph Hospital   (United States)

^b PRESBYTERIAN ST LUKE S MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B LIPID COMPLEX; AZTREONAM; GANCICLOVIR; INFLIXIMAB; MERCAPTOPURINE; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; VANCOMYCIN;

ADULT; CASE REPORT; CLINICAL FEATURE; CROHN DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG USE; ENDOSCOPY; FEVER; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEMOPHAGOCYTIC SYNDROME; HUMAN; ILEITIS; INTESTINE ULCER; LETTER; MALE; NAUSEA; PRIORITY JOURNAL; SPLENOMEGALY; SYMPTOM; VOMITING;

EID: 33144457493     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/500262     Document Type: Letter

References (4)

1. Haerter G, Manfras BJ, de Jong-Hesse Y, et al. Cytomegalovirus retinitis in a patient treated with anti-tumor necrosis factor alpha antibody therapy for rheumatoid arthritis. Clin Infect Dis 2004;39:e88-94.
2. Mizuta M, Schuster MG. Cytomegalovirus hepatitis associated with use of anti-tumor necrosis factor-α antibody. Clin Infect Dis 2005; 40: 1071-2.
3. Geist LJ, Monick MM, Stinski MF, Hunninghake GW. The immediate early genes of human cytomegalovirus upregulate tumor necrosis factor-α gene expression. J Clin Invest 1994; 93:474-78.
4. Van Deventer SJH. Tumour necrosis factor and Crohn's disease. Gut 1997; 40:443-8.